End-of-day quote
Other stock markets
|
||
- USD | - |
|
06-18 | Cantor Fitzgerald Initiates Innoviva at Overweight Rating | MT |
06-10 | Transcript : Innoviva, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 01:20 PM |
Sales 2024 * | 303M 415M | Sales 2025 * | 319M 437M | Capitalization | 1.02B 1.39B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 4.09 x |
Net Debt 2024 * | 224M 307M | Net Debt 2025 * | 145M 198M | EV / Sales 2025 * | 3.64 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.49% |
Latest transcript on Theravance Inc
Managers | Title | Age | Since |
---|---|---|---|
Pavel Raifeld
CEO | Chief Executive Officer | 40 | 20-05-19 |
Stephen Basso
DFI | Director of Finance/CFO | 58 | 23-08-20 |
Marianne Zhen
AUD | Comptroller/Controller/Auditor | 55 | 14-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 18-02-11 | |
Director/Board Member | 53 | 22-12-31 | |
Jules Haimovitz
BRD | Director/Board Member | 73 | 18-02-11 |
1st Jan change | Capi. | |
---|---|---|
+54.61% | 811B | |
+43.48% | 640B | |
-6.33% | 353B | |
+20.62% | 333B | |
+10.44% | 302B | |
+17.91% | 246B | |
+2.41% | 225B | |
+12.61% | 218B | |
+8.61% | 168B |